Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a protein infusion cut dangerous fluid buildup in liver disease?

NCT ID NCT05867602

First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 28 times

Summary

This study tests whether giving a higher dose of albumin (a protein) to people with advanced liver cirrhosis and hard-to-treat fluid buildup (ascites) can reduce the need for frequent fluid drainage procedures. About 100 adults with cirrhosis and refractory ascites will receive either high-dose or standard-dose albumin infusions. The goal is to see if the higher dose lowers complications and improves outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASCITES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Baylor St' Lukes Medical center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.